Recent genetic evidence has shown that the age of onset of Alzheimer's disease (AD) correlates inversely with the concentration of the apolipoprotein E (apoE) variant 4. How the single amino acid change from variant 3 to variant 4 leads to neurodegeneration and tangles is not understood. There are two obvious routes of action of apoE that could lead to neurodegeneration; either, apoE4 could be entering the cell cytoplasm through a transmembrane flip process in the endocytic pathway or it could be inducing a signal that results in the degenerative process. We propose to follow the paths of uptake of apoE3 and E4 in dorsal root ganglion (DRG) neurons as well as the responses that they stimulate to differentiate between the possible mechanisms. Our long-term interest in neuronal transport and processing has stimulated us to address the question of the biological differences between apoE3 and E4 and how they might affect neuronal and biochemical differences between the two forms have been observed and we will determine if and how those differences can result in changes in cellular motility. Using specifically tagged apoEs and/or specific antibodies, we will follow the fate of the apoEs and the stimuli that they elicit. We will characterize the changes in axon extension and branching caused by apoE4 and will analyze its effect on microtubule- dependent motility. These studies will identify the cellular pathway of apoE processing and the bases of its effects on motility.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005128-15
Application #
6267244
Study Section
Project Start
1998-05-01
Project End
1999-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23

Showing the most recent 10 out of 97 publications